razoxane has been researched along with Thrombopenia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofland, KF; Jensen, PB; Sehested, M; Thougaard, AV | 1 |
| Cullinan, S; Everson, L; Gerstner, J; Krook, J; Laurie, J; McCormack, G; Schutt, A; Scott, M; Shreck, R; Windschitl, H | 1 |
| Blessing, JA; Conroy, JF; Homesley, HD; Kessinger, A | 1 |
| Blessing, JA; Conroy, JF; Hatch, K; Lewis, GC; Mangan, C; Wilbanks, G | 1 |
| Kaplan, BH; Lanham, R; Vogl, SE | 1 |
| Begg, CB; Glick, JH; O'Connell, MJ; Oken, MM; Silverstein, MN | 1 |
| Phillips, KA; Tannock, IF | 1 |
| Green, MR; Herndon, JE; Kindler, HL; Kosty, MP; Vogelzang, NJ | 1 |
| Hassenstein, E; Renner, K | 1 |
1 review(s) available for razoxane and Thrombopenia
| Article | Year |
|---|---|
Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy.
Topics: Amifostine; Antineoplastic Agents; Cardiovascular Agents; Clinical Trials, Phase III as Topic; Heart Diseases; Hematopoietic Cell Growth Factors; Humans; Leukopoiesis; Randomized Controlled Trials as Topic; Razoxane; Research Design; Thrombocytopenia | 1998 |
4 trial(s) available for razoxane and Thrombopenia
| Article | Year |
|---|---|
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Evaluation; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Nausea; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Stomatitis; Thrombocytopenia; Triazines; Vomiting | 1983 |
Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Folic Acid Antagonists; Humans; Leukopenia; Nausea; Piperazines; Razoxane; Rectal Neoplasms; Thrombocytopenia; Triazines | 1980 |
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomas.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Myeloproliferative Disorders; Piperazines; Probability; Prognosis; Razoxane; Thrombocytopenia | 1980 |
High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Heart Diseases; Humans; Male; Mesothelioma; Middle Aged; Neutropenia; Razoxane; Thrombocytopenia | 2001 |
5 other study(ies) available for razoxane and Thrombopenia
| Article | Year |
|---|---|
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
Topics: Anemia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cell Culture Techniques; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Etoposide; Female; Leukopenia; Mice; Neutropenia; Razoxane; Thrombocytopenia | 2005 |
Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperazines; Razoxane; Thrombocytopenia | 1984 |
ICRF-159 (razoxane) in patients with advanced squamous cell carcinoma of the uterine cervix. For the Gynecologic Oncology Group.
Topics: Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukopenia; Piperazines; Razoxane; Thrombocytopenia; Uterine Cervical Neoplasms | 1984 |
[Study on hematological toxicity in irradiation and ICRF 159 combination treatment during experimentation on animals with particular consideration of long-term effects (author's transl)].
Topics: Animals; Blood Cell Count; Blood Platelets; Female; Hematopoiesis; Leukocyte Count; Leukopenia; Mice; Piperazines; Razoxane; Specific Pathogen-Free Organisms; Thrombocytopenia; Time Factors | 1978 |
Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Agents; Deoxyguanosine; Dianhydrogalactitol; Drug Evaluation; Humans; Leukopenia; Pancreatic Neoplasms; Piperazines; Razoxane; Sugar Alcohols; Thionucleosides; Thrombocytopenia; Triazines | 1985 |